Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Cellectis' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $8.8 million for Q4 2024.

• In Q4 2024, Accumulated Expenses fell 5.74% year-over-year to $8.8 million; the TTM figure through Dec 2024 stood at $8.8 million (down 5.74% YoY), while the FY2024 annual figure was $8.8 million, down 5.74% from the prior year.
• Accumulated Expenses was $8.8 million for Q4 2024 at Cellectis, down from $9.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.4 million in Q4 2022 to a low of $167000.0 in Q1 2021.
• Historically, Accumulated Expenses has averaged $4.8 million across 4 years, with a median of $4.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses jumped 2679.06% in 2022, then decreased 5.74% in 2024.
• A 4-year view of Accumulated Expenses shows it stood at $339000.0 in 2021, then surged by 2679.06% to $9.4 million in 2022, then declined by 0.56% to $9.4 million in 2023, then decreased by 5.74% to $8.8 million in 2024.
• The last three Accumulated Expenses figures came in at $8.8 million (Q4 2024), $9.4 million (Q4 2023), and $9.4 million (Q4 2022), per Business Quant data.